本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Viridian Therapeutics, Inc.

15.67
+0.44002.89%
盘后15.670.00000.00%16:20 EDT
成交量:39.64万
成交额:622.15万
市值:12.79亿
市盈率:-4.70
高:15.94
开:15.17
低:14.98
收:15.23
数据加载中...
2023/02/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/06

重要事件披露

8-K - Current report
2023/01/26

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/09

重要事件披露

8-K - Current report
2022/11/14

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/19

重要事件披露

8-K - Current report
2022/08/19

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/08/16

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/08/16

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/08/16

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/08/16

重要事件披露

8-K - Current report
2022/08/15

重要事件披露

8-K - Current report
2022/08/15

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/06/23

重要事件披露

8-K - Current report
2022/06/10

重要事件披露

8-K - Current report
2022/05/31

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/05/19

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/05/13

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/12

重要事件披露

8-K - Current report